Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lader, Malcolm
1998.
The relevance of recent advances in psychopharmacology for social psychiatry.
Epidemiologia e Psichiatria Sociale,
Vol. 7,
Issue. 2,
p.
77.
Wilhelm, Kay
1998.
The Relevance of Smoking and Nicotine to Clinical Psychiatry.
Australasian Psychiatry,
Vol. 6,
Issue. 3,
p.
130.
Percudani, Mauro
and
Knapp, Martin
1998.
The economic perspective in the care and treatment of patients with diagnosis of schizophrenia.
Epidemiologia e Psichiatria Sociale,
Vol. 7,
Issue. 3,
p.
197.
Waddington, John L.
Youssef, Hanafy A.
and
Kinsella, Anthony
1998.
Mortality in schizophrenia.
British Journal of Psychiatry,
Vol. 173,
Issue. 4,
p.
325.
1998.
Review: patients who have schizophrenia have increased mortality from all causes, natural causes, and unnatural causes.
Evidence Based Mental Health,
Vol. 1,
Issue. 3,
p.
91.
Landén, Mikael
Davidsson, Pia
Gottfries, Carl-Gerhard
Stridsberg, Bengt GrenfeldtMats
and
Blennow, Kaj
1999.
Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia.
Biological Psychiatry,
Vol. 46,
Issue. 12,
p.
1698.
Harrison, Paul J.
1999.
The neuropathology of schizophrenia.
Brain,
Vol. 122,
Issue. 4,
p.
593.
Hewer, W.
1999.
Psychiatrie der Gegenwart 4.
p.
289.
Horrobin, D. F.
and
Bennett, C. N.
1999.
Search for the Causes of Schizophrenia.
p.
261.
Santhouse, Alistair
and
Holloway, Frank
1999.
Physical health of patients in continuing care.
Advances in Psychiatric Treatment,
Vol. 5,
Issue. 6,
p.
455.
Landén, Mikael
Grenfeldt, Bengt
Davidsson, Pia
Stridsberg, Mats
Regland, Björn
Gottfries, Carl-Gerhard
and
Blennow, Kaj
1999.
Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia.
European Neuropsychopharmacology,
Vol. 9,
Issue. 4,
p.
311.
Kilian, Jens G
Kerr, Kristin
Lawrence, Christopher
and
Celermajer, David S
1999.
Myocarditis and cardiomyopathy associated with clozapine.
The Lancet,
Vol. 354,
Issue. 9193,
p.
1841.
Percudani, M.
Fattore, G.
Galletta, J.
Mita, P. L.
Contini, A.
and
Altamura, A. C.
1999.
Health care costs of therapy‐refractory schizophrenic patients treated with clozapine: a study in a community psychiatric service in Italy.
Acta Psychiatrica Scandinavica,
Vol. 99,
Issue. 4,
p.
274.
Green, Alan I
Patel, Jayendra K
Goisman, Robert M
Allison, David B
and
Blackburn, George
2000.
Weight gain from novel antipsychotic drugs: need for action.
General Hospital Psychiatry,
Vol. 22,
Issue. 4,
p.
224.
Davidson, Sandra
Judd, Fiona
Jolley, Damien
Hocking, Barbara
and
Thompson, Sandra
2000.
The General Health Status of People with Mental Illness.
Australasian Psychiatry,
Vol. 8,
Issue. 1,
p.
31.
Goldman, Larry S.
2000.
Comorbid medical illness in psychiatric patients.
Current Psychiatry Reports,
Vol. 2,
Issue. 3,
p.
256.
Lara, D.R.
and
Souza, D.O.
2000.
Schizophrenia: a purinergic hypothesis.
Medical Hypotheses,
Vol. 54,
Issue. 2,
p.
157.
De Hert, Marc
and
Peuskens, Jozef
2000.
The International Handbook of Suicide and Attempted Suicide.
p.
121.
Sami Räsänen, Antti Pakaslahti, Erk
2000.
Sex differences in schizophrenia: A review.
Nordic Journal of Psychiatry,
Vol. 54,
Issue. 1,
p.
37.
Brown, Steve
Inskip, Hazel
and
Barraclough, Brian
2000.
Causes of the excess mortality of schizophrenia.
British Journal of Psychiatry,
Vol. 177,
Issue. 3,
p.
212.
eLetters
No eLetters have been published for this article.